XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Capital Surplus
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Balance at Beginning of Period at Dec. 31, 2019 $ 1,286,832 $ 3,632   $ 579 $ 582,566 $ (31,112) $ 1,761,415 $ 3,632 $ (1,026,616)
Beginning Balance (in shares) at Dec. 31, 2019       40,039,695          
Increase (decrease) in shareholders' equity                  
Net Income 34,742           34,742    
Other Comprehensive Income (Loss) $ 41,933         41,933      
Accounting Standards Update Extensible List Accounting Standards Update 2016-13                
Share-Based Compensation $ 1,497       1,497        
Common Stock Issued under Purchase and Equity Compensation Plans 3,761       329   653   2,779
Common Stock Issued under Purchase and Equity Compensation Plans and Related Tax Benefits (in shares)       154,091          
Common Stock Repurchased (17,633)               (17,633)
Common Stock Repurchased (in shares)       (197,276)          
Cash Dividends Declared Common Stock (per share) (26,835)           (26,835)    
Balance at End of Period at Mar. 31, 2020 1,327,929     $ 579 584,392 10,821 1,773,607   (1,041,470)
Ending Balance (in shares) at Mar. 31, 2020       39,996,510          
Balance at Beginning of Period at Dec. 31, 2019 1,286,832 $ 3,632   $ 579 582,566 (31,112) 1,761,415 $ 3,632 (1,026,616)
Beginning Balance (in shares) at Dec. 31, 2019       40,039,695          
Increase (decrease) in shareholders' equity                  
Net Income 73,650                
Other Comprehensive Income (Loss) 50,037         50,037      
Balance at End of Period at Jun. 30, 2020 1,352,082     $ 580 586,946 18,925 1,786,351   (1,040,720)
Ending Balance (in shares) at Jun. 30, 2020       40,047,694          
Balance at Beginning of Period at Mar. 31, 2020 1,327,929     $ 579 584,392 10,821 1,773,607   (1,041,470)
Beginning Balance (in shares) at Mar. 31, 2020       39,996,510          
Increase (decrease) in shareholders' equity                  
Net Income 38,908           38,908    
Other Comprehensive Income (Loss) 8,104         8,104      
Share-Based Compensation 2,207       2,207        
Common Stock Issued under Purchase and Equity Compensation Plans 1,926     $ 1 347   680   898
Common Stock Issued under Purchase and Equity Compensation Plans and Related Tax Benefits (in shares)       53,672          
Common Stock Repurchased (148)               (148)
Common Stock Repurchased (in shares)       (2,488)          
Cash Dividends Declared Common Stock (per share) (26,844)           (26,844)    
Balance at End of Period at Jun. 30, 2020 1,352,082     $ 580 586,946 18,925 1,786,351   (1,040,720)
Ending Balance (in shares) at Jun. 30, 2020       40,047,694          
Balance at Beginning of Period at Dec. 31, 2020 1,374,507     $ 580 591,360 7,822 1,811,979   (1,037,234)
Beginning Balance (in shares) at Dec. 31, 2020       40,119,312          
Increase (decrease) in shareholders' equity                  
Net Income 59,949           59,949    
Other Comprehensive Income (Loss) (49,609)         (49,609)      
Share-Based Compensation 2,780       2,780        
Common Stock Issued under Purchase and Equity Compensation Plans 2,809       664   (845)   2,990
Common Stock Issued under Purchase and Equity Compensation Plans and Related Tax Benefits (in shares)       310,905          
Common Stock Repurchased (3,189)               (3,189)
Common Stock Repurchased (in shares)       (35,983)          
Cash Dividends Declared Common Stock (per share) (27,026)           (27,026)    
Balance at End of Period at Mar. 31, 2021 1,360,221     $ 580 594,804 (41,787) 1,844,057   (1,037,433)
Ending Balance (in shares) at Mar. 31, 2021       40,394,234          
Balance at Beginning of Period at Dec. 31, 2020 1,374,507     $ 580 591,360 7,822 1,811,979   (1,037,234)
Beginning Balance (in shares) at Dec. 31, 2020       40,119,312          
Increase (decrease) in shareholders' equity                  
Net Income 127,482                
Other Comprehensive Income (Loss) (49,290)         (49,290)      
Balance at End of Period at Jun. 30, 2021 1,583,531   $ 180,000 $ 580 594,261 (41,468) 1,884,431   (1,034,273)
Ending Balance (in shares) at Jun. 30, 2021     180,000 40,465,482          
Balance at Beginning of Period at Mar. 31, 2021 1,360,221     $ 580 594,804 (41,787) 1,844,057   (1,037,433)
Beginning Balance (in shares) at Mar. 31, 2021       40,394,234          
Increase (decrease) in shareholders' equity                  
Net Income 67,533           67,533    
Other Comprehensive Income (Loss) 319         319      
Share-Based Compensation 3,342       3,342        
Preferred Stock Issued, Net 175,487   $ 180,000   (4,513)        
Preferred Stock Issued, Net (in shares)     180,000            
Common Stock Issued under Purchase and Equity Compensation Plans 3,851       628   (46)   3,269
Common Stock Issued under Purchase and Equity Compensation Plans and Related Tax Benefits (in shares)       72,421          
Common Stock Repurchased (109)               (109)
Common Stock Repurchased (in shares)       (1,173)          
Cash Dividends Declared Common Stock (per share) (27,113)           (27,113)    
Balance at End of Period at Jun. 30, 2021 $ 1,583,531   $ 180,000 $ 580 $ 594,261 $ (41,468) $ 1,884,431   $ (1,034,273)
Ending Balance (in shares) at Jun. 30, 2021     180,000 40,465,482